Population
49-year-old man treated with fluoxetine
Design
Case_report
Follow-up
2 days after withdrawal
Authors
Loading...
Fluoxetine may induce reversible platelet defects warranting caution in bleeding patients; single case leaves open population bleeding risk and monitoring needs.
Fluoxetine therapy may be associated with reversible abnormal platelet aggregation, likely due to the parent drug's effect on serotonin reuptake in platelets.
Alderman et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: